falsefalse

Post-Conference Perspectives: Updates in Colorectal Cancer: Highlights from ASCO GI 2023 and Beyond - Episode 1

An Introduction to Biomarker Testing in Metastatic Colorectal Cancer

Tanios S. Bekaii-Saab, MD, FACP introduces the metastatic colorectal cancer (mCRC) treatment landscape and the emphasizes importance of biomarker testing in patients with mCRC.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    Now Viewing
    EP. 1: An Introduction to Biomarker Testing in Metastatic Colorectal Cancer
    EP. 2: Clinical Trial Review: MOUNTAINEER
    EP. 3: MOUNTAINEER-03 Clinical Trial Study Design and Implications
    EP. 4: Emerging Treatment Options for Patients with HER2+ Metastatic Colorectal Cancer
    EP. 5: The Future of the Metastatic Colorectal Cancer Treatment Landscape

    Related Content:

    Post-Conference Perspectives: Updates in Colorectal Cancer: Highlights from ASCO GI 2023 and BeyondOncLive News Network®
    Key Areas of Future Research in Advanced Melanoma
    Where RP1 Plus Nivolumab Could Fit in the Treatment Paradigm for Advanced Melanoma Post–PD-1 Inhibition
    Data for RP1 Plus Nivolumab in Metastatic Melanoma After Prior PD-1 Inhibition
    x